WARREN, N.J. – GSK Consumer Healthcare, the maker of Advil, today announced its commitment to reducing the plastic in over 80 million Advil bottles by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By 2022, Advil will have reduced the plastic in nearly all bottles available in stores and online.
The initiative is a first-of-its-kind sustainable plastic technology for over-the-counter (OTC) medicines. This new barrier resin technology reduces the amount of resin required to mold and craft the bottles, while maintaining the same barrier protection properties. It allows for a 20% reduction in material usage for high-density polyethylene (HDPE) bottles that will never enter the environmental waste stream, without a reduction to critical performance characteristics of the bottle.
The new sustainability goal set by Advil is part of GSK’s ambition for all consumer product packaging to be recyclable or reusable, including eliminating all problematic and unnecessary plastics when permitted, while ensuring the quality, safety and efficacy of our products, by 2025.
“As a world leader in pain relief, we at GSK are proud to transition Advil to a more environmentally friendly packaging, further supporting GSK’s commitment to sustainability,” said Sarah McDonald, VP of Sustainability, GSK Consumer Healthcare. “With the new technology available to us, we saw this as an opportunity to invest in the future of our brands and sustainability goals. Advil’s switch to 20% less plastic is a first in the OTC category, and kicks off a series of plastic reduction initiatives across the product portfolio at GSK.”
The focus on plastics and packaging is informed by the leading requirements set by the Ellen Macarthur Foundation. GSK joined the Ellen MacArthur Network in 2020 and is committed to playing its part in mobilizing a shift towards a circular economy for plastics.
As part of their 2025 sustainability commitment, GSK also joined the Action for Sustainable Derivatives (ASD), which aims to increase the transparency and traceability of palm oil derivatives supply chains. In collaboration with ASD, GSK introduced the Sustainable Palm Index (SPI), an evaluation scorecard for suppliers of palm oil and palm kernel oil derivatives, intended to support procurement decisions.
Further, last year GSK announced ambitious new environmental sustainability goals in both climate and nature, aiming to have a net zero impact on climate and a net positive impact on nature by 2030.
GSK has already begun transitioning Advil’s bottles to 20% less plastic, and the Advil portfolio will have transitioned by 2022, online and on retail shelves nationwide. To learn more about Advil and GSK’s sustainability initiatives, visit GSK.com.